Overview

A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

Status:
Not yet recruiting
Trial end date:
2022-07-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects on the single-dose drug levels of mavacamten in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb